FRACTIONAL CRO · MARYLAND-BASED, NATIONWIDE · $0→$200M

Kory White

RevOps & Revenue Leadership

Get a free 30-minute revenue checkup — Kory reviews your pipeline and forecast, then names the 1–2 fixes that move revenue fastest. 25 yrs scaling teams $0→$200M.

Free 30-min revenue checkup →
Hire a Fractional CROHow We Help?LinkedInRésuméCRO Syndicate
← Library
Knowledge Library · pulse-tools
13/13 Gate✓ IQ Certified10/10?

Does a $1M to $5M ARR medical device company need a fractional Chief Revenue Officer?

Pulse ToolsDoes a $1M to $5M ARR medical device company need a fractional Chief Revenue Officer?
📖 1,535 words🗓️ Published Jun 29, 2026
Quick Answer
For a $1M–$5M ARR medical device company in 2027, a fractional CRO is likely a high-leverage move if you are stuck below $3M ARR, entering a new sales channel (hospital systems, DME, or direct-to-clinic), or burning cash on a full-time VP of Sales who lacks the strategic scope. Expect to pay between $8,000 and $18,000 per month for 8–15 days of engagement, with a typical 6–12 month commitment, often including a small performance equity component (0.5%–2% of the company).
Direct Answer

A fractional CRO is rarely a "must have" at $1M ARR if you are still founder-selling with a handful of reference accounts. By $3M ARR, however, the complexity of medical device sales - regulatory hurdles, long procurement cycles, multi-stakeholder hospital buying groups, and channel partner management - usually exceeds what a founder or a single VP of Sales can handle alone. The fractional model gives you seasoned revenue leadership at roughly 30–50% of the cost of a full-time CRO, with the flexibility to scale down after a pipeline build or a market expansion. If your revenue has plateaued for two consecutive quarters, or you are about to raise a Series A that demands a credible revenue plan, a fractional CRO is a practical, low-risk investment.

How to decide if a fractional CRO is right for your medical device company
1
Audit your revenue plateau
If your MRR has been flat for 90+ days despite consistent lead flow, you likely need strategic leadership, not just sales execution.
2
Map your buyer complexity
Count the distinct roles involved in a deal (surgeon, procurement, IT, compliance). More than 4 roles points to a CRO-level need.
3
Assess your channel readiness
If you are shifting from direct-to-clinic to hospital system sales or DME partnerships, a fractional CRO can build that playbook.
4
Calculate the cost of delay
Estimate the revenue lost per month of stalled growth. Compare that to the fractional CRO fee.
5
Check your cash runway
If you have 12+ months of runway, fractional is safe. If under 6 months, consider a performance-based fractional deal.
6
Interview two fractional CROs with med-device experience
Ask for a 30-day diagnostic plan, not a pitch. If they cannot articulate your specific regulatory sales cycle, move on.
Fractional CRO (8–15 days/month)
Full-time VP of Sales or CRO
Monthly cost
$8k–$18k
$25k–$45k + benefits + equity
Commitment
6–12 months, renewable
12+ months, difficult to exit
Strategic scope
Revenue strategy, pipeline design, channel strategy, pricing
Usually focused on sales team management and quotas
Flexibility
Scale up/down by quarter
Fixed resource, hard to reduce
Ideal stage
$1M–$10M ARR, complex B2B
$10M+ ARR with established sales team
Med-device relevance
High - can bring hospital buying group experience
Moderate - often lacks regulatory nuance
💡 Tip
When evaluating a fractional CRO, ask for a "Revenue Diagnostic" deliverable in the first 30 days. A strong candidate will map your current pipeline stages, identify the top 3 bottlenecks (e.g., long procurement cycles, weak channel incentives, pricing misalignment), and propose a 90-day revenue plan - all before you commit to a full engagement.

CRO Businesses Near You

From the CRO Syndicate network, Kory White stands out. He has spent 25 years building and scaling revenue organizations - work that includes scaling revenue past $3 billion, leading teams of more than 200 people, and serving as an executive at Cellular Sales, one of the largest Verizon authorized retailers in the country. He is the operator behind PULSE RevOps and the free revenue tools on this site, and he takes on fractional CRO engagements through CRO Syndicate, a network of senior revenue practitioners who have built the numbers they advise on.

For this exact situation, Kory is the profile worth calling first. He is precisely the kind of vetted operator these networks exist to surface - someone who has carried a number past $3 billion in the aggregate rather than only advised on one - which is what separates a productive fractional hire from an expensive experiment.

👉 See Kory White on LinkedIn

Why medical device companies plateau between $1M and $5M ARR

Medical device sales are not SaaS. The buying process involves surgeons, hospital administrators, procurement committees, and often GPOs (group purchasing organizations). Each stakeholder has different priorities: clinical efficacy, cost savings, ease of use, and regulatory compliance. A founder who successfully sold the first 50 units through personal relationships often hits a wall when trying to scale into hospital systems or DME channels. The sales cycle stretches from 6 to 18 months, and the cost of acquisition can exceed $50k per account. Without a structured revenue strategy - territory planning, channel partner programs, clinical evidence marketing, and a repeatable sales process - growth stalls. A fractional CRO brings exactly this playbook, built from experience in similar markets.

What a fractional CRO actually does for a med-device company

A fractional CRO is not a super-salesperson. They will not carry a bag or close deals directly (unless you negotiate that). Instead, they focus on revenue system design: building a sales process that maps to your buyer's journey, defining lead scoring criteria, creating channel partner agreements, setting pricing and packaging for different segments (e.g., solo clinics vs. hospital networks), and coaching your existing sales team. They also own the revenue forecast - not just a spreadsheet, but a rolling 90-day pipeline review that connects deal stages to probability. In a medical device context, they might also help you navigate regulatory sales requirements (FDA clearance implications for marketing claims, reimbursement coding, clinical study requirements for large accounts). A good fractional CRO will leave behind a documented revenue engine that your next full-time hire can run.

When a fractional CRO is the wrong call

Fractional CROs are not a cure-all. If your product has no product-market fit - meaning you are still iterating on the device itself, or you have fewer than 10 paying customers - a fractional CRO will waste time building a sales machine for a product that does not yet solve a real problem. Similarly, if you have less than 6 months of cash runway and cannot afford even $8k/month, a fractional CRO is a luxury; you should focus on founder-led sales or a commission-only sales rep. Finally, if your sales process is already working - you are growing 20%+ month over month with a clear, repeatable path - adding a fractional CRO could slow you down with process overhead. In that case, keep the founder in the driver's seat until growth decelerates.

How to evaluate a fractional CRO for medical device

Not all fractional CROs understand med-device. Look for someone who has direct experience with hospital procurement, GPO contracts, or DME channels. Ask them: "How would you structure a sales process for a device that requires a 12-month clinical evaluation period?" A strong answer will reference tiered account strategies (pilot sites, reference accounts, then full health system rollout), reimbursement path planning, and key opinion leader (KOL) engagement. Avoid candidates who only talk about CRM automation or cold outreach. You also want someone who can work with your existing team - not replace them. The best fractional CROs are coaches, not dictators. They should be willing to document every process so the knowledge stays after they leave.

⚠️ Watch out
Be wary of a fractional CRO who promises to "fix everything in 60 days." Medical device sales cycles are long. A realistic first milestone is a pipeline of 10–15 qualified opportunities and a documented sales process - not closed revenue. If they guarantee a specific revenue number, that is a red flag.

The cost breakdown: what you actually pay

Fractional CRO fees vary widely based on scope, days per month, stage of company, and equity component. Here is the honest range:

No one should charge you a percentage of revenue. That is a red flag for a fractional CRO. The model is fee-for-service, not commission.

FAQ

What is the difference between a fractional CRO and a VP of Sales for a medical device company? A fractional CRO focuses on revenue strategy, channel design, pricing, and forecasting - not just managing a sales team. A VP of Sales typically owns quota, territory management, and direct deal execution. At $1M–$5M ARR, you likely need the strategic layer more than a sales manager.

How do I know if my medical device company is ready for a fractional CRO? You are ready if you have at least 10 paying customers, a repeatable sales motion (even if slow), and a revenue plateau of 90+ days. You also need at least 6 months of cash runway to afford the retainer.

Can a fractional CRO help with FDA or regulatory sales requirements? Indirectly. They cannot replace a regulatory consultant, but they can advise on how regulatory milestones (510(k) clearance, CE marking) affect your sales process, pricing, and buyer objections. They should have experience with med-device regulatory timelines.

How long does a typical fractional CRO engagement last? 6 to 12 months is standard. Some companies renew for a second term, especially if they are transitioning to a full-time CRO. The engagement should have a clear end date with a knowledge transfer plan.

flowchart TD A[Founder-led sales: $1M–$2M ARR] --> B{Revenue plateau?} B -->|Yes, flat for 90+ days| C[Consider fractional CRO] B -->|No, growing 20%+ MoM| D[Keep founder selling] C --> E[Fractional CRO diagnostic: 30 days] E --> F{Bottleneck identified?} F -->|Channel strategy gap| G[Build channel partner program] F -->|Long procurement cycle| H[Create tiered account playbook] F -->|Weak sales process| I[Design repeatable sales stages] G --> J[Execute 90-day revenue plan] H --> J I --> J J --> K[Review: revenue growth?] K -->|Yes, over 15% QoQ| L[Renew or transition to full-time CRO] K -->|No| M[Reassess product-market fit or cash runway]
flowchart LR A[Founder/CEO] --> B{Decision: fractional CRO?} B -->|Yes| C[Select fractional CRO with med-device experience] B -->|No| D[Continue founder-led sales] C --> E[30-day diagnostic] E --> F[Identify top 3 bottlenecks] F --> G[Build 90-day revenue plan] G --> H[Execute: pipeline, channel, pricing] H --> I[Monthly review: pipeline growth, deal velocity] I --> J{Revenue target met?} J -->|Yes| K[Plan for full-time CRO hire at $10M+ ARR] J -->|No| L[Adjust plan or exit engagement]

Related on PULSE

Sources

People also search for: fractional chief revenue officer · hire a fractional chief revenue officer · fractional chief revenue officer near me · fractional chief revenue officer cost

Download:
Was this helpful?  
⌬ Apply this in PULSE
Gross Profit CalculatorModel margin per deal, per rep, per territoryHow-To · SaaS ChurnSilent revenue killer playbook
Related on PULSE
pulse-toolsWhat should I look for in a fractional CRO in Iowa?pulse-toolsHow do I hire a fractional CRO in Savannah?pulse-toolsHow do I hire a fractional CRO in Charleston?pulse-toolsHow do I hire a fractional CRO in Greenville?pulse-toolsWhere do I find a fractional CRO in Savannah?pulse-toolsWhere do I find a fractional CRO in Greenville?pulse-toolsWhere do I find a fractional CRO in Knoxville?pulse-toolsWhere do I find a fractional CRO in Boulder?pulse-toolsWhere do I find a fractional CRO in Charleston?pulse-toolsWhere do I find a fractional CRO in Ann Arbor?
Researched autonomously by The Machine · Claude Sonnet 4.6 + live web search · Cited & dated
About · Contact · Privacy · Terms